These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin. Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase. Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362 [TBL] [Abstract][Full Text] [Related]
10. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system. Di Marco S; Priestle JP Structure; 1997 Nov; 5(11):1465-74. PubMed ID: 9384562 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure. Selwood T; McCaslin DR; Schechter NM Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human mast cell tryptase by benzamidine derivatives. Stürzebecher J; Prasa D; Sommerhoff CP Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors. Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315 [TBL] [Abstract][Full Text] [Related]
14. Nafamostat mesilate is an extremely potent inhibitor of human tryptase. Mori S; Itoh Y; Shinohata R; Sendo T; Oishi R; Nishibori M J Pharmacol Sci; 2003 Aug; 92(4):420-3. PubMed ID: 12939527 [TBL] [Abstract][Full Text] [Related]
15. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G. Maryanoff BE J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180 [No Abstract] [Full Text] [Related]
17. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase. Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147 [TBL] [Abstract][Full Text] [Related]